$4.05
-$0.10
(-2.41%)
Quote as of 4:00 PM EST on 02/10/12
Dynavax Technologies Corp
NASDAQ:DVAX
Extended Hours:
$4.04
-$0.01
(-0.25%)
Quote as of 5:15 PM EST on 02/10/12 (NASDAQ)
|
$4.05
-$0.10
(-2.41%)
|
|
| Today's Open | $4.15 |
|---|---|
| Previous Close | $4.15 |
| Daily Range | $3.94 - $4.19 |
| 52-Week Range | $1.75 - $4.48 |
| Market Cap | $513.58M |
| P/E Ratio | -8.47 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,816,938 |
| Average Daily Volume | 1,721,678 |
| Current FY EPS | -$0.43 |
DVAX Information
| Description |
|---|
| A biopharmaceutical company that discovers and develops Toll-like Receptor 9 and agonist-based products to treat and prevent infectious diseases, allergies, cancer and chronic inflammatory. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Insiders Are Not Buying Into the Rally: Cause for Concern?
Dynavax Shares Popped: What You Need to Know
The 2 Best-Performing Sectors Over the Last Decade
US Commerce Official To Lead Biotech Trade Mission To China, Hong Kong
10 Health Care Penny Stocks to Buy
17 Stocks Under $5 Being Chased by Big Money Managers
7 Breakout Stocks With Sufficient Cash to Cover Operating Expenses
20 Short Seller Targets Under $5
